New oligosaccharides prepared by acid hydrolysis of the polysaccharides from Nerium indicum Mill and their anti-angiogenesis activities

Carbohydrate Research

Volumn 344, Issue 2, 2009, Pages 198-203

  Hu, Ke ^a,b   Liu, Qin ^b   Wang, Shunchun ^a   Ding, Kan ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Anti angiogenesis activity; Galactooligosaccharide; Nerium indicum

Indexed keywords

ACID HYDROLYSES; ANTI-ANGIOGENESIS ACTIVITY; CANCER THERAPEUTICS; DRUG CANDIDATES; GALACTAN; GALACTO OLIGOSACCHARIDES; GALACTOOLIGOSACCHARIDE; HEXASACCHARIDE; HUMAN MICROVASCULAR ENDOTHELIAL CELLS; IN VITRO; METHYLATION ANALYSIS; NERIUM INDICUM; NMR SPECTROSCOPIES; PENTASACCHARIDE; SUGAR ANALYSIS; TUBE FORMATIONS;

ACIDS; BIOPOLYMERS; ENDOTHELIAL CELLS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUGAR (SUCROSE); SUGARS;

POLYSACCHARIDES;

GALACTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE OJ1; GALACTOSE OLIGOSACCHARIDE OJ2; GALACTOSE OLIGOSACCHARIDE OJ3; NERIUM INDICUM EXTRACT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; MASS SPECTROMETRY; METHYLATION; NERIUM; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; CELL DIFFERENTIATION; CELL LINE; HUMANS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NERIUM; OLIGOSACCHARIDES; POLYSACCHARIDES;

NERIUM OLEANDER;

EID: 57749206798     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carres.2008.10.019     Document Type: Article

References (27)

1. Ding K., Fang J.N., Dong T., Tsim K.W., and Wu H. J. Nat. Prod. 66 (2003) 7-10
2. Institute of Materia Medica, Chinese Academy of Medical Sciences. Studies on Effective Constituents of Traditional Chinese Medicine. 1st ed. (1972), The People's Health Press, Beijing pp 392-396
3. Dong Q., and Fang J.N. Carbohydr. Res. 332 (2001) 109-114
4. Mueller B.M., Rosskopf F., Paper D.H., and Kraus J. Pharmazie 46 (1991) 657-663
5. Li W.Y., Dong Q., and Fang J.N. Chin. Trad. Herb. Drugs 30 (1999) 891-893
6. Yu M.S., So K.F., and Fang J.N. Brain Res. 1153 (2007) 221-230
7. Lin Z.B., and Zhang H.N. Acta Pharmacol. Sinica 25 (2004) 1387-1395
8. Leung M.Y., Liu C., and Koon J.C. Immunol. Lett. 105 (2006) 101-114
9. Yu M.S., Lai S.W., Lin K.F., and Fang J.N. Int. J. Mol. Med. 14 (2004) 917-924
10. Carabin J.G., and Flamm W.G. Regul. Toxicol. Pharm. 3 (1999) 268-282
11. Spiegel J., Karabell P., and Frankos V.H. Food Technol. 48 (1994) 85-89
12. Kim M. Nutr. Res. 20 (2000) 1017-1026
13. Zhao H., Liu H., Chen Y., Xin X., Li J., Hou Y., Zhang Z., Zhang X., Xie C., Geng M., and Ding J. Cancer Res. 66 (2006) 8779-8787
14. Blumencrantz N., and Asboe-Hansen G. Anal. Biochem. 54 (1973) 484-489
15. Dong Q., Yao J., and Fang J.N. Carbohydr. Res. 342 (2007) 1343-1349
16. Cases M.R., Cerezo A.S., and Stortz C.A. Carbohydr. Res. 269 (1995) 333-341
17. Liu L., Dong Q., and Fang J.N. Carbohydr. Polym. 70 (2007) 304-309
18. Vogl H., Paper D.H., and Franz G. Carbohydr. Polym. 41 (2000) 185-190
19. Ishii T., Ohnishi-Kameyama M., and Ono H. Planta 219 (2004) 310-318
20. Bonnin E., Voragen A.G.J., and Thibault J.F. Enzyme Microb. Technol. 19 (1996) 100-106
21. Norrby K. J. Cell. Mol. Med. 10 (2006) 588-612
22. Risau W. Nature 386 (1997) 671
23. Slevin M., Kumar S., and Gaffney J. J. Biol. Chem. 277 (2002) 41046-41059
24. Zhang C., Yang F., Zhang X.W., Wang S.C., Li M.H., Lin L.P., and Ding J. Br. J. Pharmacol. 148 (2006) 741-751
25. Wang S., Annie Bligh S.W., Zhu C., Shi S., Wang Z., Hu Z., Crowder J., Branford-White C., and Wella C. J. Agric. Food Chem. 56 (2008) 2624-2629
26. Needs P.W., and Selvendran R.R. Carbohydr. Res. 245 (1993) 1-10
27. Dong Q., Jia L.M., and Fang J.N. Carbohydr. Res. 341 (2006) 791-795